The vaginal ring is a method of birth control that provides both estrogen and progestin hormones. You need a prescription from your health care provider. The vaginal ring is also used to treat conditions such as irregular periods, menstrual crampsor endometriosis.
NuvaRing is a flexible, transparent contraceptive ring that is inserted by a woman into her vagina. NuvaRing releases a continuous low dosage of the synthetic hormones estrogen and progestin. The ring stops ovulation.
Etonogestrel and ethinylestradiol are released from the ring at a rate of 0. NuvaRing is a contraceptive vaginal ring used to prevent pregnancy. Each ring contains a small amount of two female sex hormones - etonogestrel and ethinylestradiol.
Written by SpunOut View this authors Twitter page and posted in health. The vaginal ring is a low dose hormonal contraceptive. For someone who has trouble remembering to take the pill every day, the vaginal ring, also known as the NuvaRing, could be great alternative, as it's not something you need to remember every day.
NuvaRing contains 2 kinds of female hormones, estrogen and progestin, which work together to prevent pregnancy. They are the same kind of hormones found in the pill and they work the same way to prevent pregnancy even though they are administered differently with NuvaRing. Once you place NuvaRing in your vagina, it releases a continuous low dose of hormones that helps prevent pregnancy.
Back to Your contraception guide. It releases a continuous dose of the hormones oestrogen and progestogen into the bloodstream to prevent pregnancy. The ring steadily releases the hormones oestrogen and progestogen into your bloodstream, which prevents the release of an egg each month.
Safari browser is no longer supported on Windows. It has known security flaws and will display this website and others incorrectly. Your experience will be compromised.
Author: Felicia H. Peer Reviewer: Kurt T. NuvaRing, approved by the Food and Drug Administration FDA in Novemberprovides a low-dose, steady release of estrogen ethinyl estradiol and progestin etonogestrel, the active form of desogestrel for three weeks of continuous wear.
The findings in the non-comparative studies were confirmed in the RCTs. After study completion, women using NuvaRing were more likely to continue with their method than women using a COC. The good results with respect to contraceptive efficacy, cycle control, tolerability, and acceptability as achieved with NuvaRing in the large non-comparative registration studies were confirmed in the RCTs comparing NuvaRing with different COCs.